FC
Finepoint Capital’s Relay Therapeutics RLAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,117,646
| Closed | -$5.55M | – | 18 |
|
|
2025
Q1 | $5.55M | Sell |
2,117,646
-58,000
| -3% | -$152K | 0.42% | 15 |
|
|
2024
Q4 | $8.96M | Buy |
2,175,646
+549,500
| +34% | +$2.26M | 0.55% | 16 |
|
|
2024
Q3 | $11.5M | Buy |
1,626,146
+20,800
| +1% | +$147K | 0.84% | 14 |
|
|
2024
Q2 | $10.5M | Buy |
1,605,346
+115,176
| +8% | +$751K | 2.97% | 13 |
|
|
2024
Q1 | $12.4M | Buy |
1,490,170
+172,300
| +13% | +$1.43M | 3.17% | 16 |
|
|
2023
Q4 | $14.5M | Buy |
1,317,870
+447,000
| +51% | +$4.92M | 4.58% | 11 |
|
|
2023
Q3 | $7.32M | Buy |
870,870
+169,300
| +24% | +$1.42M | 3.65% | 15 |
|
|
2023
Q2 | $8.81M | Sell |
701,570
-144,700
| -17% | -$1.82M | 3.05% | 19 |
|
|
2023
Q1 | $13.9M | Buy |
846,270
+131,422
| +18% | +$2.16M | 5.32% | 14 |
|
|
2022
Q4 | $10.7M | Buy |
+714,848
| New | +$10.7M | 3.45% | 17 |
|